Latest News about BIIB
Recent news which mentions BIIB
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
From Benzinga
Thinking Of Buying Boston Properties? Here Are The Properties And Tenants You'd Add To Your Portfolio
June 07, 2023
From Benzinga
Biogen and Denali Realign Parkinson's Disease Research Priorities Amidst R&D Restructure
June 05, 2023
From Benzinga
From MarketWatch
From MarketWatch
New Alzheimer’s drug could bring hope to patients, but could be out of reach for people on Medicare
May 25, 2023
Tickers
BIIB
From MarketWatch
From InvestorPlace
1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market
May 19, 2023
From Motley Fool
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
May 04, 2023
From Benzinga
Eli Lilly’s positive results from a Alzheimer’s trial seen as ‘potentially very important’
May 03, 2023
From MarketWatch
Why Eli Lilly Stock Is Bolting Higher Today
May 03, 2023
From Motley Fool
From Benzinga
Eli Lilly stock jumps 8% after Alzheimer’s treatment slows disease progression in major trial
May 03, 2023
From MarketWatch
From Benzinga
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.